Renaissance Capital logo

GWB News

US IPO Weekly Recap: 5 IPOs achieve moderate gains during the market slide and a biotech rejection

DM

Five initial public offerings collectively raised $1.3 billion during the past week, bringing the year's total to 228 IPOs and $73.5 billion raised, a 35% increase over this time last year by deal count and an 84% increase by proceeds. The S&P 500 had the largest 3-day slide since 2011 while the VIX volatility index leapt above 25 and the IPO market responded with postponed...read more

Forward Pharma goes backward: year's largest biotech drops 17% on IPO

DM

One step Forward, two steps back Forward Pharma (FWP), which is developing an alternative to and challenging the IP of Biogen Idec's multi-billion dollar Tecfidera treatment for MS, raised $221 and finished its first day down 17%. It was the year's 7th-worst first-day performance out of 226 IPOs. The biotech first appeared to defy poor market conditions by pricing at...read more

Great Western Bancorp raises $288 million after pricing IPO at $18, below the range

GWB

Great Western Bancorp, an agribusiness-focused Midwestern bank with 162 branches and $9 billion in assets, raised $288 million, 20% less than anticipated, by offering 16 million shares at $18, below the range of $21 to $24. Great Western Bancorp plans to list on the NYSE under the symbol GWB. Deutsche Bank and BofA Merrill Lynch acted as lead managers on the deal....read more

7 US IPOs planned for the week of October 13, including the IPO market's biotech test

Seven initial public offerings are expected to raise $1.7 billion in the upcoming week. Four IPOs are biotechs, including Forward Pharma, which could be the year's largest (and 60th), and three others in early stages of development. Consolidated fiber optic network Zayo Group is expected raise $650 million to be the week's largest deal. We should also see the IPOs of midstream...read more